Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · page 12 of 38
The slide outlines a standard clinical trial progression for SAD and MAD cohorts, including randomization ratios and participant types.
Pitch deck · appendix_methodology · present_framework · dense density
Slide locked Sign in to view
Slide schematic 6/6
diagram 2/2 list 2/2 paragraph 1/1 title 1/1
Components 6
process process bullet bullet paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1